Global CMO and CDMO Market Research Report 2025(Status and Outlook)
Report Overview
The CMO and CDMO market encompasses third-party service providers that support pharmaceutical and biotechnology companies by offering manufacturing and development services for drugs and biologics. CMOs primarily focus on manufacturing drugs on behalf of sponsors, including active pharmaceutical ingredients (API), intermediates, and finished dosage forms (FDF) such as tablets, injectables, and inhalers. CDMOs combine drug development services?formulation, process development, analytical testing?with manufacturing capabilities. These organizations enable clients to outsource complex manufacturing tasks, scale production, and accelerate time-to-market while maintaining regulatory compliance. The market features a wide range of services including chemical synthesis, biologics manufacturing, aseptic filling, and packaging, serving small molecules, biologics, and advanced therapies.
The global CMO and CDMO market size was estimated at USD XX million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CMO and CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CMO and CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CMO and CDMO market
Global CMO and CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Group
Thermo Fisher Scientific
Catalent
WuXi Biologics
Samsung Biologics
Boehringer Ingelheim BioXcellence
Fujifilm Diosynth Biotechnologies
Recipharm
Pfizer CentreOne
Charles River Laboratories
AGC Biologics
Jubilant Life Sciences
Alcami Corporation
Evonik Industries
Piramal Pharma Solutions
MilliporeSigma
KBI Biopharma
AbbVie
Emergent BioSolutions
Rentschler Biopharma
Sterling Pharma Solutions
Aenova
Market Segmentation (by Type)
CMO
CDMO
Market Segmentation (by Application)
Small Molecule Pharmaceuticals
Biologics and Biosimilars
Advanced Therapy Medicinal Products (ATMPs)
Vaccines
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CMO and CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CMO and CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The CMO and CDMO market encompasses third-party service providers that support pharmaceutical and biotechnology companies by offering manufacturing and development services for drugs and biologics. CMOs primarily focus on manufacturing drugs on behalf of sponsors, including active pharmaceutical ingredients (API), intermediates, and finished dosage forms (FDF) such as tablets, injectables, and inhalers. CDMOs combine drug development services?formulation, process development, analytical testing?with manufacturing capabilities. These organizations enable clients to outsource complex manufacturing tasks, scale production, and accelerate time-to-market while maintaining regulatory compliance. The market features a wide range of services including chemical synthesis, biologics manufacturing, aseptic filling, and packaging, serving small molecules, biologics, and advanced therapies.
The global CMO and CDMO market size was estimated at USD XX million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CMO and CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CMO and CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CMO and CDMO market
Global CMO and CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Group
Thermo Fisher Scientific
Catalent
WuXi Biologics
Samsung Biologics
Boehringer Ingelheim BioXcellence
Fujifilm Diosynth Biotechnologies
Recipharm
Pfizer CentreOne
Charles River Laboratories
AGC Biologics
Jubilant Life Sciences
Alcami Corporation
Evonik Industries
Piramal Pharma Solutions
MilliporeSigma
KBI Biopharma
AbbVie
Emergent BioSolutions
Rentschler Biopharma
Sterling Pharma Solutions
Aenova
Market Segmentation (by Type)
CMO
CDMO
Market Segmentation (by Application)
Small Molecule Pharmaceuticals
Biologics and Biosimilars
Advanced Therapy Medicinal Products (ATMPs)
Vaccines
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the CMO and CDMO Market
- Overview of the regional outlook of the CMO and CDMO Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CMO and CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CMO and CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CMO and CDMO
1.2 Key Market Segments
1.2.1 CMO and CDMO Segment by Type
1.2.2 CMO and CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CMO AND CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CMO AND CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CMO and CDMO Product Life Cycle
3.3 Global CMO and CDMO Revenue Market Share by Company (2020-2025)
3.4 CMO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 CMO and CDMO Company Headquarters, Area Served, Product Type
3.6 CMO and CDMO Market Competitive Situation and Trends
3.6.1 CMO and CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest CMO and CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CMO AND CDMO VALUE CHAIN ANALYSIS
4.1 CMO and CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CMO AND CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CMO and CDMO Market Porter's Five Forces Analysis
6 CMO AND CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CMO and CDMO Market Size Market Share by Type (2020-2025)
6.3 Global CMO and CDMO Market Size Growth Rate by Type (2021-2025)
7 CMO AND CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CMO and CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global CMO and CDMO Sales Growth Rate by Application (2020-2025)
8 CMO AND CDMO MARKET SEGMENTATION BY REGION
8.1 Global CMO and CDMO Market Size by Region
8.1.1 Global CMO and CDMO Market Size by Region
8.1.2 Global CMO and CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America CMO and CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CMO and CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific CMO and CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CMO and CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CMO and CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza Group
9.1.1 Lonza Group Basic Information
9.1.2 Lonza Group CMO and CDMO Product Overview
9.1.3 Lonza Group CMO and CDMO Product Market Performance
9.1.4 Lonza Group SWOT Analysis
9.1.5 Lonza Group Business Overview
9.1.6 Lonza Group Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Basic Information
9.2.2 Thermo Fisher Scientific CMO and CDMO Product Overview
9.2.3 Thermo Fisher Scientific CMO and CDMO Product Market Performance
9.2.4 Thermo Fisher Scientific SWOT Analysis
9.2.5 Thermo Fisher Scientific Business Overview
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Catalent
9.3.1 Catalent Basic Information
9.3.2 Catalent CMO and CDMO Product Overview
9.3.3 Catalent CMO and CDMO Product Market Performance
9.3.4 Catalent SWOT Analysis
9.3.5 Catalent Business Overview
9.3.6 Catalent Recent Developments
9.4 WuXi Biologics
9.4.1 WuXi Biologics Basic Information
9.4.2 WuXi Biologics CMO and CDMO Product Overview
9.4.3 WuXi Biologics CMO and CDMO Product Market Performance
9.4.4 WuXi Biologics Business Overview
9.4.5 WuXi Biologics Recent Developments
9.5 Samsung Biologics
9.5.1 Samsung Biologics Basic Information
9.5.2 Samsung Biologics CMO and CDMO Product Overview
9.5.3 Samsung Biologics CMO and CDMO Product Market Performance
9.5.4 Samsung Biologics Business Overview
9.5.5 Samsung Biologics Recent Developments
9.6 Boehringer Ingelheim BioXcellence
9.6.1 Boehringer Ingelheim BioXcellence Basic Information
9.6.2 Boehringer Ingelheim BioXcellence CMO and CDMO Product Overview
9.6.3 Boehringer Ingelheim BioXcellence CMO and CDMO Product Market Performance
9.6.4 Boehringer Ingelheim BioXcellence Business Overview
9.6.5 Boehringer Ingelheim BioXcellence Recent Developments
9.7 Fujifilm Diosynth Biotechnologies
9.7.1 Fujifilm Diosynth Biotechnologies Basic Information
9.7.2 Fujifilm Diosynth Biotechnologies CMO and CDMO Product Overview
9.7.3 Fujifilm Diosynth Biotechnologies CMO and CDMO Product Market Performance
9.7.4 Fujifilm Diosynth Biotechnologies Business Overview
9.7.5 Fujifilm Diosynth Biotechnologies Recent Developments
9.8 Recipharm
9.8.1 Recipharm Basic Information
9.8.2 Recipharm CMO and CDMO Product Overview
9.8.3 Recipharm CMO and CDMO Product Market Performance
9.8.4 Recipharm Business Overview
9.8.5 Recipharm Recent Developments
9.9 Pfizer CentreOne
9.9.1 Pfizer CentreOne Basic Information
9.9.2 Pfizer CentreOne CMO and CDMO Product Overview
9.9.3 Pfizer CentreOne CMO and CDMO Product Market Performance
9.9.4 Pfizer CentreOne Business Overview
9.9.5 Pfizer CentreOne Recent Developments
9.10 Charles River Laboratories
9.10.1 Charles River Laboratories Basic Information
9.10.2 Charles River Laboratories CMO and CDMO Product Overview
9.10.3 Charles River Laboratories CMO and CDMO Product Market Performance
9.10.4 Charles River Laboratories Business Overview
9.10.5 Charles River Laboratories Recent Developments
9.11 AGC Biologics
9.11.1 AGC Biologics Basic Information
9.11.2 AGC Biologics CMO and CDMO Product Overview
9.11.3 AGC Biologics CMO and CDMO Product Market Performance
9.11.4 AGC Biologics Business Overview
9.11.5 AGC Biologics Recent Developments
9.12 Jubilant Life Sciences
9.12.1 Jubilant Life Sciences Basic Information
9.12.2 Jubilant Life Sciences CMO and CDMO Product Overview
9.12.3 Jubilant Life Sciences CMO and CDMO Product Market Performance
9.12.4 Jubilant Life Sciences Business Overview
9.12.5 Jubilant Life Sciences Recent Developments
9.13 Alcami Corporation
9.13.1 Alcami Corporation Basic Information
9.13.2 Alcami Corporation CMO and CDMO Product Overview
9.13.3 Alcami Corporation CMO and CDMO Product Market Performance
9.13.4 Alcami Corporation Business Overview
9.13.5 Alcami Corporation Recent Developments
9.14 Evonik Industries
9.14.1 Evonik Industries Basic Information
9.14.2 Evonik Industries CMO and CDMO Product Overview
9.14.3 Evonik Industries CMO and CDMO Product Market Performance
9.14.4 Evonik Industries Business Overview
9.14.5 Evonik Industries Recent Developments
9.15 Piramal Pharma Solutions
9.15.1 Piramal Pharma Solutions Basic Information
9.15.2 Piramal Pharma Solutions CMO and CDMO Product Overview
9.15.3 Piramal Pharma Solutions CMO and CDMO Product Market Performance
9.15.4 Piramal Pharma Solutions Business Overview
9.15.5 Piramal Pharma Solutions Recent Developments
9.16 MilliporeSigma
9.16.1 MilliporeSigma Basic Information
9.16.2 MilliporeSigma CMO and CDMO Product Overview
9.16.3 MilliporeSigma CMO and CDMO Product Market Performance
9.16.4 MilliporeSigma Business Overview
9.16.5 MilliporeSigma Recent Developments
9.17 KBI Biopharma
9.17.1 KBI Biopharma Basic Information
9.17.2 KBI Biopharma CMO and CDMO Product Overview
9.17.3 KBI Biopharma CMO and CDMO Product Market Performance
9.17.4 KBI Biopharma Business Overview
9.17.5 KBI Biopharma Recent Developments
9.18 AbbVie
9.18.1 AbbVie Basic Information
9.18.2 AbbVie CMO and CDMO Product Overview
9.18.3 AbbVie CMO and CDMO Product Market Performance
9.18.4 AbbVie Business Overview
9.18.5 AbbVie Recent Developments
9.19 Emergent BioSolutions
9.19.1 Emergent BioSolutions Basic Information
9.19.2 Emergent BioSolutions CMO and CDMO Product Overview
9.19.3 Emergent BioSolutions CMO and CDMO Product Market Performance
9.19.4 Emergent BioSolutions Business Overview
9.19.5 Emergent BioSolutions Recent Developments
9.20 Rentschler Biopharma
9.20.1 Rentschler Biopharma Basic Information
9.20.2 Rentschler Biopharma CMO and CDMO Product Overview
9.20.3 Rentschler Biopharma CMO and CDMO Product Market Performance
9.20.4 Rentschler Biopharma Business Overview
9.20.5 Rentschler Biopharma Recent Developments
9.21 Sterling Pharma Solutions
9.21.1 Sterling Pharma Solutions Basic Information
9.21.2 Sterling Pharma Solutions CMO and CDMO Product Overview
9.21.3 Sterling Pharma Solutions CMO and CDMO Product Market Performance
9.21.4 Sterling Pharma Solutions Business Overview
9.21.5 Sterling Pharma Solutions Recent Developments
9.22 Aenova
9.22.1 Aenova Basic Information
9.22.2 Aenova CMO and CDMO Product Overview
9.22.3 Aenova CMO and CDMO Product Market Performance
9.22.4 Aenova Business Overview
9.22.5 Aenova Recent Developments
10 CMO AND CDMO MARKET FORECAST BY REGION
10.1 Global CMO and CDMO Market Size Forecast
10.2 Global CMO and CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CMO and CDMO Market Size Forecast by Country
10.2.3 Asia Pacific CMO and CDMO Market Size Forecast by Region
10.2.4 South America CMO and CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of CMO and CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global CMO and CDMO Market Forecast by Type (2026-2033)
11.2 Global CMO and CDMO Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CMO and CDMO
1.2 Key Market Segments
1.2.1 CMO and CDMO Segment by Type
1.2.2 CMO and CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CMO AND CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CMO AND CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CMO and CDMO Product Life Cycle
3.3 Global CMO and CDMO Revenue Market Share by Company (2020-2025)
3.4 CMO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 CMO and CDMO Company Headquarters, Area Served, Product Type
3.6 CMO and CDMO Market Competitive Situation and Trends
3.6.1 CMO and CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest CMO and CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CMO AND CDMO VALUE CHAIN ANALYSIS
4.1 CMO and CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CMO AND CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CMO and CDMO Market Porter's Five Forces Analysis
6 CMO AND CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CMO and CDMO Market Size Market Share by Type (2020-2025)
6.3 Global CMO and CDMO Market Size Growth Rate by Type (2021-2025)
7 CMO AND CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CMO and CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global CMO and CDMO Sales Growth Rate by Application (2020-2025)
8 CMO AND CDMO MARKET SEGMENTATION BY REGION
8.1 Global CMO and CDMO Market Size by Region
8.1.1 Global CMO and CDMO Market Size by Region
8.1.2 Global CMO and CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America CMO and CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CMO and CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific CMO and CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CMO and CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CMO and CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza Group
9.1.1 Lonza Group Basic Information
9.1.2 Lonza Group CMO and CDMO Product Overview
9.1.3 Lonza Group CMO and CDMO Product Market Performance
9.1.4 Lonza Group SWOT Analysis
9.1.5 Lonza Group Business Overview
9.1.6 Lonza Group Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Basic Information
9.2.2 Thermo Fisher Scientific CMO and CDMO Product Overview
9.2.3 Thermo Fisher Scientific CMO and CDMO Product Market Performance
9.2.4 Thermo Fisher Scientific SWOT Analysis
9.2.5 Thermo Fisher Scientific Business Overview
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Catalent
9.3.1 Catalent Basic Information
9.3.2 Catalent CMO and CDMO Product Overview
9.3.3 Catalent CMO and CDMO Product Market Performance
9.3.4 Catalent SWOT Analysis
9.3.5 Catalent Business Overview
9.3.6 Catalent Recent Developments
9.4 WuXi Biologics
9.4.1 WuXi Biologics Basic Information
9.4.2 WuXi Biologics CMO and CDMO Product Overview
9.4.3 WuXi Biologics CMO and CDMO Product Market Performance
9.4.4 WuXi Biologics Business Overview
9.4.5 WuXi Biologics Recent Developments
9.5 Samsung Biologics
9.5.1 Samsung Biologics Basic Information
9.5.2 Samsung Biologics CMO and CDMO Product Overview
9.5.3 Samsung Biologics CMO and CDMO Product Market Performance
9.5.4 Samsung Biologics Business Overview
9.5.5 Samsung Biologics Recent Developments
9.6 Boehringer Ingelheim BioXcellence
9.6.1 Boehringer Ingelheim BioXcellence Basic Information
9.6.2 Boehringer Ingelheim BioXcellence CMO and CDMO Product Overview
9.6.3 Boehringer Ingelheim BioXcellence CMO and CDMO Product Market Performance
9.6.4 Boehringer Ingelheim BioXcellence Business Overview
9.6.5 Boehringer Ingelheim BioXcellence Recent Developments
9.7 Fujifilm Diosynth Biotechnologies
9.7.1 Fujifilm Diosynth Biotechnologies Basic Information
9.7.2 Fujifilm Diosynth Biotechnologies CMO and CDMO Product Overview
9.7.3 Fujifilm Diosynth Biotechnologies CMO and CDMO Product Market Performance
9.7.4 Fujifilm Diosynth Biotechnologies Business Overview
9.7.5 Fujifilm Diosynth Biotechnologies Recent Developments
9.8 Recipharm
9.8.1 Recipharm Basic Information
9.8.2 Recipharm CMO and CDMO Product Overview
9.8.3 Recipharm CMO and CDMO Product Market Performance
9.8.4 Recipharm Business Overview
9.8.5 Recipharm Recent Developments
9.9 Pfizer CentreOne
9.9.1 Pfizer CentreOne Basic Information
9.9.2 Pfizer CentreOne CMO and CDMO Product Overview
9.9.3 Pfizer CentreOne CMO and CDMO Product Market Performance
9.9.4 Pfizer CentreOne Business Overview
9.9.5 Pfizer CentreOne Recent Developments
9.10 Charles River Laboratories
9.10.1 Charles River Laboratories Basic Information
9.10.2 Charles River Laboratories CMO and CDMO Product Overview
9.10.3 Charles River Laboratories CMO and CDMO Product Market Performance
9.10.4 Charles River Laboratories Business Overview
9.10.5 Charles River Laboratories Recent Developments
9.11 AGC Biologics
9.11.1 AGC Biologics Basic Information
9.11.2 AGC Biologics CMO and CDMO Product Overview
9.11.3 AGC Biologics CMO and CDMO Product Market Performance
9.11.4 AGC Biologics Business Overview
9.11.5 AGC Biologics Recent Developments
9.12 Jubilant Life Sciences
9.12.1 Jubilant Life Sciences Basic Information
9.12.2 Jubilant Life Sciences CMO and CDMO Product Overview
9.12.3 Jubilant Life Sciences CMO and CDMO Product Market Performance
9.12.4 Jubilant Life Sciences Business Overview
9.12.5 Jubilant Life Sciences Recent Developments
9.13 Alcami Corporation
9.13.1 Alcami Corporation Basic Information
9.13.2 Alcami Corporation CMO and CDMO Product Overview
9.13.3 Alcami Corporation CMO and CDMO Product Market Performance
9.13.4 Alcami Corporation Business Overview
9.13.5 Alcami Corporation Recent Developments
9.14 Evonik Industries
9.14.1 Evonik Industries Basic Information
9.14.2 Evonik Industries CMO and CDMO Product Overview
9.14.3 Evonik Industries CMO and CDMO Product Market Performance
9.14.4 Evonik Industries Business Overview
9.14.5 Evonik Industries Recent Developments
9.15 Piramal Pharma Solutions
9.15.1 Piramal Pharma Solutions Basic Information
9.15.2 Piramal Pharma Solutions CMO and CDMO Product Overview
9.15.3 Piramal Pharma Solutions CMO and CDMO Product Market Performance
9.15.4 Piramal Pharma Solutions Business Overview
9.15.5 Piramal Pharma Solutions Recent Developments
9.16 MilliporeSigma
9.16.1 MilliporeSigma Basic Information
9.16.2 MilliporeSigma CMO and CDMO Product Overview
9.16.3 MilliporeSigma CMO and CDMO Product Market Performance
9.16.4 MilliporeSigma Business Overview
9.16.5 MilliporeSigma Recent Developments
9.17 KBI Biopharma
9.17.1 KBI Biopharma Basic Information
9.17.2 KBI Biopharma CMO and CDMO Product Overview
9.17.3 KBI Biopharma CMO and CDMO Product Market Performance
9.17.4 KBI Biopharma Business Overview
9.17.5 KBI Biopharma Recent Developments
9.18 AbbVie
9.18.1 AbbVie Basic Information
9.18.2 AbbVie CMO and CDMO Product Overview
9.18.3 AbbVie CMO and CDMO Product Market Performance
9.18.4 AbbVie Business Overview
9.18.5 AbbVie Recent Developments
9.19 Emergent BioSolutions
9.19.1 Emergent BioSolutions Basic Information
9.19.2 Emergent BioSolutions CMO and CDMO Product Overview
9.19.3 Emergent BioSolutions CMO and CDMO Product Market Performance
9.19.4 Emergent BioSolutions Business Overview
9.19.5 Emergent BioSolutions Recent Developments
9.20 Rentschler Biopharma
9.20.1 Rentschler Biopharma Basic Information
9.20.2 Rentschler Biopharma CMO and CDMO Product Overview
9.20.3 Rentschler Biopharma CMO and CDMO Product Market Performance
9.20.4 Rentschler Biopharma Business Overview
9.20.5 Rentschler Biopharma Recent Developments
9.21 Sterling Pharma Solutions
9.21.1 Sterling Pharma Solutions Basic Information
9.21.2 Sterling Pharma Solutions CMO and CDMO Product Overview
9.21.3 Sterling Pharma Solutions CMO and CDMO Product Market Performance
9.21.4 Sterling Pharma Solutions Business Overview
9.21.5 Sterling Pharma Solutions Recent Developments
9.22 Aenova
9.22.1 Aenova Basic Information
9.22.2 Aenova CMO and CDMO Product Overview
9.22.3 Aenova CMO and CDMO Product Market Performance
9.22.4 Aenova Business Overview
9.22.5 Aenova Recent Developments
10 CMO AND CDMO MARKET FORECAST BY REGION
10.1 Global CMO and CDMO Market Size Forecast
10.2 Global CMO and CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CMO and CDMO Market Size Forecast by Country
10.2.3 Asia Pacific CMO and CDMO Market Size Forecast by Region
10.2.4 South America CMO and CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of CMO and CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global CMO and CDMO Market Forecast by Type (2026-2033)
11.2 Global CMO and CDMO Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CMO and CDMO Market Size Comparison by Region (M USD)
Table 5. Global CMO and CDMO Revenue (M USD) by Company (2020-2025)
Table 6. Global CMO and CDMO Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO and CDMO as of 2024)
Table 8. CMO and CDMO Company Headquarters and Area Served
Table 9. Company CMO and CDMO Product Type
Table 10. Global CMO and CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. CMO and CDMO Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global CMO and CDMO Market Size by Type (M USD)
Table 21. Global CMO and CDMO Market Size (M USD) by Type (2020-2025)
Table 22. Global CMO and CDMO Market Size Share by Type (2020-2025)
Table 23. Global CMO and CDMO Market Size Growth Rate by Type (2021-2025)
Table 24. Global CMO and CDMO Market Size by Application
Table 25. Global CMO and CDMO Market Size by Application (2020-2025) & (M USD)
Table 26. Global CMO and CDMO Market Share by Application (2020-2025)
Table 27. Global CMO and CDMO Sales Growth Rate by Application (2020-2025)
Table 28. Global CMO and CDMO Market Size by Region (2020-2025) & (M USD)
Table 29. Global CMO and CDMO Market Size Market Share by Region (2020-2025)
Table 30. North America CMO and CDMO Market Size by Country (2020-2025) & (M USD)
Table 31. Europe CMO and CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific CMO and CDMO Market Size by Region (2020-2025) & (M USD)
Table 33. South America CMO and CDMO Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa CMO and CDMO Market Size by Region (2020-2025) & (M USD)
Table 35. Lonza Group Basic Information
Table 36. Lonza Group CMO and CDMO Product Overview
Table 37. Lonza Group CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Lonza Group SWOT Analysis
Table 39. Lonza Group Business Overview
Table 40. Lonza Group Recent Developments
Table 41. Thermo Fisher Scientific Basic Information
Table 42. Thermo Fisher Scientific CMO and CDMO Product Overview
Table 43. Thermo Fisher Scientific CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Thermo Fisher Scientific SWOT Analysis
Table 45. Thermo Fisher Scientific Business Overview
Table 46. Thermo Fisher Scientific Recent Developments
Table 47. Catalent Basic Information
Table 48. Catalent CMO and CDMO Product Overview
Table 49. Catalent CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Catalent SWOT Analysis
Table 51. Catalent Business Overview
Table 52. Catalent Recent Developments
Table 53. WuXi Biologics Basic Information
Table 54. WuXi Biologics CMO and CDMO Product Overview
Table 55. WuXi Biologics CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 56. WuXi Biologics Business Overview
Table 57. WuXi Biologics Recent Developments
Table 58. Samsung Biologics Basic Information
Table 59. Samsung Biologics CMO and CDMO Product Overview
Table 60. Samsung Biologics CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Samsung Biologics Business Overview
Table 62. Samsung Biologics Recent Developments
Table 63. Boehringer Ingelheim BioXcellence Basic Information
Table 64. Boehringer Ingelheim BioXcellence CMO and CDMO Product Overview
Table 65. Boehringer Ingelheim BioXcellence CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Boehringer Ingelheim BioXcellence Business Overview
Table 67. Boehringer Ingelheim BioXcellence Recent Developments
Table 68. Fujifilm Diosynth Biotechnologies Basic Information
Table 69. Fujifilm Diosynth Biotechnologies CMO and CDMO Product Overview
Table 70. Fujifilm Diosynth Biotechnologies CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Fujifilm Diosynth Biotechnologies Business Overview
Table 72. Fujifilm Diosynth Biotechnologies Recent Developments
Table 73. Recipharm Basic Information
Table 74. Recipharm CMO and CDMO Product Overview
Table 75. Recipharm CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Recipharm Business Overview
Table 77. Recipharm Recent Developments
Table 78. Pfizer CentreOne Basic Information
Table 79. Pfizer CentreOne CMO and CDMO Product Overview
Table 80. Pfizer CentreOne CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Pfizer CentreOne Business Overview
Table 82. Pfizer CentreOne Recent Developments
Table 83. Charles River Laboratories Basic Information
Table 84. Charles River Laboratories CMO and CDMO Product Overview
Table 85. Charles River Laboratories CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Charles River Laboratories Business Overview
Table 87. Charles River Laboratories Recent Developments
Table 88. AGC Biologics Basic Information
Table 89. AGC Biologics CMO and CDMO Product Overview
Table 90. AGC Biologics CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 91. AGC Biologics Business Overview
Table 92. AGC Biologics Recent Developments
Table 93. Jubilant Life Sciences Basic Information
Table 94. Jubilant Life Sciences CMO and CDMO Product Overview
Table 95. Jubilant Life Sciences CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Jubilant Life Sciences Business Overview
Table 97. Jubilant Life Sciences Recent Developments
Table 98. Alcami Corporation Basic Information
Table 99. Alcami Corporation CMO and CDMO Product Overview
Table 100. Alcami Corporation CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Alcami Corporation Business Overview
Table 102. Alcami Corporation Recent Developments
Table 103. Evonik Industries Basic Information
Table 104. Evonik Industries CMO and CDMO Product Overview
Table 105. Evonik Industries CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Evonik Industries Business Overview
Table 107. Evonik Industries Recent Developments
Table 108. Piramal Pharma Solutions Basic Information
Table 109. Piramal Pharma Solutions CMO and CDMO Product Overview
Table 110. Piramal Pharma Solutions CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Piramal Pharma Solutions Business Overview
Table 112. Piramal Pharma Solutions Recent Developments
Table 113. MilliporeSigma Basic Information
Table 114. MilliporeSigma CMO and CDMO Product Overview
Table 115. MilliporeSigma CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 116. MilliporeSigma Business Overview
Table 117. MilliporeSigma Recent Developments
Table 118. KBI Biopharma Basic Information
Table 119. KBI Biopharma CMO and CDMO Product Overview
Table 120. KBI Biopharma CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 121. KBI Biopharma Business Overview
Table 122. KBI Biopharma Recent Developments
Table 123. AbbVie Basic Information
Table 124. AbbVie CMO and CDMO Product Overview
Table 125. AbbVie CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 126. AbbVie Business Overview
Table 127. AbbVie Recent Developments
Table 128. Emergent BioSolutions Basic Information
Table 129. Emergent BioSolutions CMO and CDMO Product Overview
Table 130. Emergent BioSolutions CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Emergent BioSolutions Business Overview
Table 132. Emergent BioSolutions Recent Developments
Table 133. Rentschler Biopharma Basic Information
Table 134. Rentschler Biopharma CMO and CDMO Product Overview
Table 135. Rentschler Biopharma CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 136. Rentschler Biopharma Business Overview
Table 137. Rentschler Biopharma Recent Developments
Table 138. Sterling Pharma Solutions Basic Information
Table 139. Sterling Pharma Solutions CMO and CDMO Product Overview
Table 140. Sterling Pharma Solutions CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 141. Sterling Pharma Solutions Business Overview
Table 142. Sterling Pharma Solutions Recent Developments
Table 143. Aenova Basic Information
Table 144. Aenova CMO and CDMO Product Overview
Table 145. Aenova CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 146. Aenova Business Overview
Table 147. Aenova Recent Developments
Table 148. Global CMO and CDMO Market Size Forecast by Region (2026-2033) & (M USD)
Table 149. North America CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Europe CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Asia Pacific CMO and CDMO Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Global CMO and CDMO Market Size Forecast by Type (2026-2033) & (M USD)
Table 155. Global CMO and CDMO Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CMO and CDMO Market Size Comparison by Region (M USD)
Table 5. Global CMO and CDMO Revenue (M USD) by Company (2020-2025)
Table 6. Global CMO and CDMO Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO and CDMO as of 2024)
Table 8. CMO and CDMO Company Headquarters and Area Served
Table 9. Company CMO and CDMO Product Type
Table 10. Global CMO and CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. CMO and CDMO Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global CMO and CDMO Market Size by Type (M USD)
Table 21. Global CMO and CDMO Market Size (M USD) by Type (2020-2025)
Table 22. Global CMO and CDMO Market Size Share by Type (2020-2025)
Table 23. Global CMO and CDMO Market Size Growth Rate by Type (2021-2025)
Table 24. Global CMO and CDMO Market Size by Application
Table 25. Global CMO and CDMO Market Size by Application (2020-2025) & (M USD)
Table 26. Global CMO and CDMO Market Share by Application (2020-2025)
Table 27. Global CMO and CDMO Sales Growth Rate by Application (2020-2025)
Table 28. Global CMO and CDMO Market Size by Region (2020-2025) & (M USD)
Table 29. Global CMO and CDMO Market Size Market Share by Region (2020-2025)
Table 30. North America CMO and CDMO Market Size by Country (2020-2025) & (M USD)
Table 31. Europe CMO and CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific CMO and CDMO Market Size by Region (2020-2025) & (M USD)
Table 33. South America CMO and CDMO Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa CMO and CDMO Market Size by Region (2020-2025) & (M USD)
Table 35. Lonza Group Basic Information
Table 36. Lonza Group CMO and CDMO Product Overview
Table 37. Lonza Group CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Lonza Group SWOT Analysis
Table 39. Lonza Group Business Overview
Table 40. Lonza Group Recent Developments
Table 41. Thermo Fisher Scientific Basic Information
Table 42. Thermo Fisher Scientific CMO and CDMO Product Overview
Table 43. Thermo Fisher Scientific CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Thermo Fisher Scientific SWOT Analysis
Table 45. Thermo Fisher Scientific Business Overview
Table 46. Thermo Fisher Scientific Recent Developments
Table 47. Catalent Basic Information
Table 48. Catalent CMO and CDMO Product Overview
Table 49. Catalent CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Catalent SWOT Analysis
Table 51. Catalent Business Overview
Table 52. Catalent Recent Developments
Table 53. WuXi Biologics Basic Information
Table 54. WuXi Biologics CMO and CDMO Product Overview
Table 55. WuXi Biologics CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 56. WuXi Biologics Business Overview
Table 57. WuXi Biologics Recent Developments
Table 58. Samsung Biologics Basic Information
Table 59. Samsung Biologics CMO and CDMO Product Overview
Table 60. Samsung Biologics CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Samsung Biologics Business Overview
Table 62. Samsung Biologics Recent Developments
Table 63. Boehringer Ingelheim BioXcellence Basic Information
Table 64. Boehringer Ingelheim BioXcellence CMO and CDMO Product Overview
Table 65. Boehringer Ingelheim BioXcellence CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Boehringer Ingelheim BioXcellence Business Overview
Table 67. Boehringer Ingelheim BioXcellence Recent Developments
Table 68. Fujifilm Diosynth Biotechnologies Basic Information
Table 69. Fujifilm Diosynth Biotechnologies CMO and CDMO Product Overview
Table 70. Fujifilm Diosynth Biotechnologies CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Fujifilm Diosynth Biotechnologies Business Overview
Table 72. Fujifilm Diosynth Biotechnologies Recent Developments
Table 73. Recipharm Basic Information
Table 74. Recipharm CMO and CDMO Product Overview
Table 75. Recipharm CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Recipharm Business Overview
Table 77. Recipharm Recent Developments
Table 78. Pfizer CentreOne Basic Information
Table 79. Pfizer CentreOne CMO and CDMO Product Overview
Table 80. Pfizer CentreOne CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Pfizer CentreOne Business Overview
Table 82. Pfizer CentreOne Recent Developments
Table 83. Charles River Laboratories Basic Information
Table 84. Charles River Laboratories CMO and CDMO Product Overview
Table 85. Charles River Laboratories CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Charles River Laboratories Business Overview
Table 87. Charles River Laboratories Recent Developments
Table 88. AGC Biologics Basic Information
Table 89. AGC Biologics CMO and CDMO Product Overview
Table 90. AGC Biologics CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 91. AGC Biologics Business Overview
Table 92. AGC Biologics Recent Developments
Table 93. Jubilant Life Sciences Basic Information
Table 94. Jubilant Life Sciences CMO and CDMO Product Overview
Table 95. Jubilant Life Sciences CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Jubilant Life Sciences Business Overview
Table 97. Jubilant Life Sciences Recent Developments
Table 98. Alcami Corporation Basic Information
Table 99. Alcami Corporation CMO and CDMO Product Overview
Table 100. Alcami Corporation CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Alcami Corporation Business Overview
Table 102. Alcami Corporation Recent Developments
Table 103. Evonik Industries Basic Information
Table 104. Evonik Industries CMO and CDMO Product Overview
Table 105. Evonik Industries CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Evonik Industries Business Overview
Table 107. Evonik Industries Recent Developments
Table 108. Piramal Pharma Solutions Basic Information
Table 109. Piramal Pharma Solutions CMO and CDMO Product Overview
Table 110. Piramal Pharma Solutions CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Piramal Pharma Solutions Business Overview
Table 112. Piramal Pharma Solutions Recent Developments
Table 113. MilliporeSigma Basic Information
Table 114. MilliporeSigma CMO and CDMO Product Overview
Table 115. MilliporeSigma CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 116. MilliporeSigma Business Overview
Table 117. MilliporeSigma Recent Developments
Table 118. KBI Biopharma Basic Information
Table 119. KBI Biopharma CMO and CDMO Product Overview
Table 120. KBI Biopharma CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 121. KBI Biopharma Business Overview
Table 122. KBI Biopharma Recent Developments
Table 123. AbbVie Basic Information
Table 124. AbbVie CMO and CDMO Product Overview
Table 125. AbbVie CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 126. AbbVie Business Overview
Table 127. AbbVie Recent Developments
Table 128. Emergent BioSolutions Basic Information
Table 129. Emergent BioSolutions CMO and CDMO Product Overview
Table 130. Emergent BioSolutions CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Emergent BioSolutions Business Overview
Table 132. Emergent BioSolutions Recent Developments
Table 133. Rentschler Biopharma Basic Information
Table 134. Rentschler Biopharma CMO and CDMO Product Overview
Table 135. Rentschler Biopharma CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 136. Rentschler Biopharma Business Overview
Table 137. Rentschler Biopharma Recent Developments
Table 138. Sterling Pharma Solutions Basic Information
Table 139. Sterling Pharma Solutions CMO and CDMO Product Overview
Table 140. Sterling Pharma Solutions CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 141. Sterling Pharma Solutions Business Overview
Table 142. Sterling Pharma Solutions Recent Developments
Table 143. Aenova Basic Information
Table 144. Aenova CMO and CDMO Product Overview
Table 145. Aenova CMO and CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 146. Aenova Business Overview
Table 147. Aenova Recent Developments
Table 148. Global CMO and CDMO Market Size Forecast by Region (2026-2033) & (M USD)
Table 149. North America CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Europe CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Asia Pacific CMO and CDMO Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa CMO and CDMO Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Global CMO and CDMO Market Size Forecast by Type (2026-2033) & (M USD)
Table 155. Global CMO and CDMO Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of CMO and CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CMO and CDMO Market Size (M USD), 2024-2033
Figure 5. Global CMO and CDMO Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. CMO and CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global CMO and CDMO Product Life Cycle
Figure 12. Global CMO and CDMO Revenue Share by Company in 2024
Figure 13. CMO and CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by CMO and CDMO Revenue in 2024
Figure 15. Value Chain Map of CMO and CDMO
Figure 16. Global CMO and CDMO Market PEST Analysis
Figure 17. Global CMO and CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global CMO and CDMO Market Share by Type
Figure 20. Market Size Share of CMO and CDMO by Type (2020-2025)
Figure 21. Market Size Share of CMO and CDMO by Type in 2024
Figure 22. Global CMO and CDMO Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global CMO and CDMO Market Share by Application
Figure 25. Global CMO and CDMO Market Share by Application (2020-2025)
Figure 26. Global CMO and CDMO Market Share by Application in 2024
Figure 27. Global CMO and CDMO Sales Growth Rate by Application (2020-2025)
Figure 28. Global CMO and CDMO Market Size Market Share by Region (2020-2025)
Figure 29. North America CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America CMO and CDMO Market Size Market Share by Country in 2024
Figure 31. U.S. CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada CMO and CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico CMO and CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe CMO and CDMO Market Share by Country in 2024
Figure 36. Germany CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific CMO and CDMO Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific CMO and CDMO Market Size Market Share by Region in 2024
Figure 43. China CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America CMO and CDMO Market Size and Growth Rate (M USD)
Figure 49. South America CMO and CDMO Market Size Market Share by Country in 2024
Figure 50. Brazil CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa CMO and CDMO Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa CMO and CDMO Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global CMO and CDMO Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global CMO and CDMO Market Share Forecast by Type (2026-2033)
Figure 62. Global CMO and CDMO Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of CMO and CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CMO and CDMO Market Size (M USD), 2024-2033
Figure 5. Global CMO and CDMO Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. CMO and CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global CMO and CDMO Product Life Cycle
Figure 12. Global CMO and CDMO Revenue Share by Company in 2024
Figure 13. CMO and CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by CMO and CDMO Revenue in 2024
Figure 15. Value Chain Map of CMO and CDMO
Figure 16. Global CMO and CDMO Market PEST Analysis
Figure 17. Global CMO and CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global CMO and CDMO Market Share by Type
Figure 20. Market Size Share of CMO and CDMO by Type (2020-2025)
Figure 21. Market Size Share of CMO and CDMO by Type in 2024
Figure 22. Global CMO and CDMO Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global CMO and CDMO Market Share by Application
Figure 25. Global CMO and CDMO Market Share by Application (2020-2025)
Figure 26. Global CMO and CDMO Market Share by Application in 2024
Figure 27. Global CMO and CDMO Sales Growth Rate by Application (2020-2025)
Figure 28. Global CMO and CDMO Market Size Market Share by Region (2020-2025)
Figure 29. North America CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America CMO and CDMO Market Size Market Share by Country in 2024
Figure 31. U.S. CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada CMO and CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico CMO and CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe CMO and CDMO Market Share by Country in 2024
Figure 36. Germany CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific CMO and CDMO Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific CMO and CDMO Market Size Market Share by Region in 2024
Figure 43. China CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America CMO and CDMO Market Size and Growth Rate (M USD)
Figure 49. South America CMO and CDMO Market Size Market Share by Country in 2024
Figure 50. Brazil CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa CMO and CDMO Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa CMO and CDMO Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa CMO and CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global CMO and CDMO Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global CMO and CDMO Market Share Forecast by Type (2026-2033)
Figure 62. Global CMO and CDMO Market Share Forecast by Application (2026-2033)
